Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
We see a great demand for effective therapies, particularly for conditions with limited treatment options. Transformative treatments, no matter how small, have the impact […]
3 things to know about the future of small molecule therapeutics Read More »
Panelists came together in a session titled “Gene Therapy: Let’s Talk about Safety, Baby,” at the 2023 Biotechnology Innovation Organization (BIO) International Convention. Gene
Gene therapy: Let’s talk about safety Read More »
According to the World Health Organization (WHO), “Cardiovascular disease (CVD) is a leading public health (and economic issue) in the United States,” a fact
Navigating patient access barriers to solve public health challenges in CVD Read More »
We have gene editing because of women—after all, Nobel Laureates Jennifer Doudna and Emmanuelle Charpentier discovered CRISPR Cas9, which kickstarted the gene-editing revolution. But
Women kickstarted the gene-editing revolution—and continue to lead the way Read More »
A cancer diagnosis is overwhelming, affecting not only a patient’s biology, but also their mental health, psycho-social status, and practical life (e.g., lives of
Cancer and mental health: improving equity and access to quality care Read More »
The Biotechnology Innovation Organization (BIO) International Convention is so much more than policy updates and panel sessions. The 2023 event, which returned to Boston
5 fun things that happened at the 2023 BIO International Convention Read More »
Access to quality healthcare is a basic human right, regardless of socioeconomic status, race, ethnicity, gender, or geographic location. Despite this, disparities in healthcare
Dismantling disparities in healthcare through partnerships and policy Read More »
Antimicrobial resistance is one of the biggest global health challenges we face. Superbugs were linked to almost 5 million deaths worldwide in 2019, and
On AMR, ‘we need to be scared’ – and pass PASTEUR Read More »
Biopharma and biomanufacturing companies are working to address climate change, both in their own supply chains and more broadly, according to a June 7
How biopharma and biomanufacturing are changing the narrative on climate challenges Read More »
From vaccine-preventable viruses to antimicrobial-resistant infections, we “need to get ahead of disease,” said Emma Walmsley, CEO of GSK, at the 2023 Biotechnology Innovation
Getting ahead of disease – with technology and partnerships Read More »
